Hypertension (High Blood Pressure) News and Research

RSS

Hypertension (or high blood pressure) is a condition where the pressure of the blood flowing through the arteries of the body is higher than it should be. Much like the pressure of the air in a tire, if the pressure of the blood is too high it can damage the arteries and organs of the body. Just like the tire, if the pressure suddenly becomes very high, catastrophic events can happen. Similarly, if the pressure remains somewhat elevated for a long enough period of time, premature wear and failure can occur.

Hypertension has its worst effects on the heart, kidneys, eyes, and brain. High blood pressure is a risk factor for heart attack, stroke, kidney failure, hemorrhages of the retina of the eye, and generalized atherosclerosis (hardening of the arteries all over the body).

Elderly mRCC patients should not be excluded from targeted therapy option

Advanced age is not a reason to preclude patients from receiving vascular endothelial growth factor-targeted therapy for metastatic renal cell carcinoma, show study findings from a mixed-age patient population.

1 Jul 2014

HIV-positive people with early-stage cancer less likely to get cancer treatment

HIV-infected people diagnosed with cancer are two to four times more likely to go untreated for their cancer compared to uninfected cancer patients, according to a new, large retrospective study from researchers in Penn Medicine's Abramson Cancer Center and the National Cancer Institute (NCI) published online ahead of print in the Journal of Clinical Oncology.

1 Jul 2014

Vitamin D boost may prevent early death from heart disease and cancer

A vitamin D boost may prevent early death from heart disease and cancer, according to a large scale study by Mount Sinai and a consortium of international collaborators, published online in the June issue of BMJ.

1 Jul 2014

BioLight enrolls first patient in FDA Phase 1/2a clinical trial with Eye-D for treatment of glaucoma

BioLight Israeli Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces that the first patient has been enrolled in the U.S. into a FDA Phase 1/2a clinical trial with Eye-D, the company's controlled-release latanoprost insert for the treatment of glaucoma.

1 Jul 2014

Causal role proposed for vitamin D in blood pressure

The results of a mendelian randomisation analysis suggest a causal link between low levels of vitamin D and increased blood pressure.

30 Jun 2014

Study calls for more proactive approach towards complete dyslipidemia diagnosis in clinical practice

Clinical inertia does not allow healthcare professionals to diagnose cholesterol problems in the 65.3% of cases. The results warn of the need to adopt a more proactive attitude towards a complete dyslipidemia diagnosis in routine clinical practice, especially if it is taken into account that it is an illness related to an increase of cardiovascular risk.

28 Jun 2014

Study finds little progress in reducing disparities among people with disabilities

Psychological distress in people with disabilities is associated with increased prevalence of other chronic conditions and reduced access to health care and preventive care services, finds a new study in the Journal of Health Care for the Poor and Underserved.

28 Jun 2014

Non-surgical gum disease treatment reduces thickness of wall of arteries

A simple non-surgical gum disease treatment markedly reduces the thickness of the wall of the arteries, a risk factor for heart disease, according to a first of its kind study among Aboriginal Australians.

28 Jun 2014

Sleep problems associated with worse memory and executive function in older people

Research published today in PLOS ONE by researchers at the University of Warwick indicates that sleep problems are associated with worse memory and executive function in older people.

28 Jun 2014

FDA approves marketing of first motorized device for patients with spinal cord injuries

The U.S. Food and Drug Administration today allowed marketing of the first motorized device intended to act as an exoskeleton for people with lower body paralysis (paraplegia) due to a spinal cord injury.

27 Jun 2014

Low vitamin D may play a role in high blood pressure

A new genetic study has provided the most solid evidence to date that a low vitamin D level plays a causal role in the development of high blood pressure (hypertension).

26 Jun 2014

Administering low doses of thyroid hormone to rats with diabetes prevents deterioration of heart function

Administering low doses of a thyroid hormone to rats with diabetes helps restore hormone levels in their hearts and prevented deterioration of heart function and pathology, according to a new study by NYIT College of Osteopathic Medicine Professor and Biomedical Sciences Chair A. Martin Gerdes.

26 Jun 2014

Aerie Pharmaceuticals' Roclatan meets all clinical endpoints in Phase 2b trial

Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today reported the successful results of its Phase 2b trial for once-daily, quadruple-action RoclatanTM, a combination of Aerie's triple-action RhopressaTM with latanoprost, a prostaglandin analogue (PGA).

25 Jun 2014

Good news for adults who suffer from insomnia

There's good news for the 30 per cent or more of adults who suffer from insomnia--difficulty falling asleep, waking up for prolonged periods during the night or unwanted early morning awakenings.

25 Jun 2014

Engaging in physical activity before attempting weight loss helps protect MetS patients from muscle loss

Younger and older women tend to lose lean muscle mass, along with fat, unless they engage in physical activity before they attempt weight loss, a new study from Israel finds. The results were presented Sunday at the joint meeting of the International Society of Endocrinology and the Endocrine Society: ICE/ENDO 2014 in Chicago.

24 Jun 2014

Functional status informs blood pressure risks in elderly

The functional status of elderly people modifies the association between their blood pressure and cardiovascular disease risk, a study shows.

23 Jun 2014

Concomitant diabetes associated with osteoarthritic hand pain

People with erosive osteoarthritis of the hand are more likely to experience pain if they have also diabetes, suggests research presented at the recent annual meeting of the European League Against Rheumatism in Paris, France.

23 Jun 2014

Empagliflozin lowers blood pressure in patients with Type 2 diabetes and hypertension

An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds.

23 Jun 2014

Empagliflozin drug reduces blood pressure in patients with Type 2 diabetes, hypertension

An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds. The results were presented Sunday in a late-breaking abstract at the joint meeting of the International Society of Endocrinology and The Endocrine Society: ICE/ENDO 2014 in Chicago.

23 Jun 2014

New treatment for ovarian cancer can improve response rates

Doctors at the University of Arizona Cancer Center at St. Joseph's Hospital and Medical Center in Phoenix reported today in Lancet Oncology that a new treatment for ovarian cancer can improve response rates (increase the rate of tumor shrinkage) and prolong the time until cancers recur.

20 Jun 2014

Hypertension (High Blood Pressure) News and Research

Further Reading

Elderly mRCC patients should not be excluded from targeted therapy option

HIV-positive people with early-stage cancer less likely to get cancer treatment

Vitamin D boost may prevent early death from heart disease and cancer

BioLight enrolls first patient in FDA Phase 1/2a clinical trial with Eye-D for treatment of glaucoma

Causal role proposed for vitamin D in blood pressure

Study calls for more proactive approach towards complete dyslipidemia diagnosis in clinical practice

Study finds little progress in reducing disparities among people with disabilities

Non-surgical gum disease treatment reduces thickness of wall of arteries

Sleep problems associated with worse memory and executive function in older people

FDA approves marketing of first motorized device for patients with spinal cord injuries

Low vitamin D may play a role in high blood pressure

Administering low doses of thyroid hormone to rats with diabetes prevents deterioration of heart function

Aerie Pharmaceuticals' Roclatan meets all clinical endpoints in Phase 2b trial

Good news for adults who suffer from insomnia

Engaging in physical activity before attempting weight loss helps protect MetS patients from muscle loss

Functional status informs blood pressure risks in elderly

Concomitant diabetes associated with osteoarthritic hand pain

Empagliflozin lowers blood pressure in patients with Type 2 diabetes and hypertension

Empagliflozin drug reduces blood pressure in patients with Type 2 diabetes, hypertension

New treatment for ovarian cancer can improve response rates

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News